Purpose A physiological balance exists between seminal reactive oxygen species (ROS) and antioxidant capacity. An overproduction of ROS which exceeds the seminal plasma antioxidant capacity results in oxidative stress (OS). The aim of the present study was to describe a detailed protocol to measure ROS in a diagnostic laboratory and revise our previous cutoff value of ROS in seminal ejaculates in a larger cohort of infertile men and controls with proven and unproven fertility. Methods A total of 258 infertile men and 92 controls were enrolled in the study. Following initial semen analysis, ROS measurement in whole ejaculates was carried out using l u m i n o l -b a s e d c h e m i l u m i n e s c e n c e a s s a y . Chemiluminescence was measured for 15 min with a Berthold luminometer. Results were expressed as relative light units (RLU/s/10 6 sperm). The test's specificity, sensitivity, and cutoff values were calculated using the receiver operating characteristic (ROC) curve. Results Significantly higher ROS levels were seen in infertile men compared to controls (p<0.001). The optimal cutoff value to differentiate between controls and infertile men was 102.2 RLU/s/10 6 sperm. At this cutoff value, the test was 76.4% sensitive and 53.3% specific. The positive and negative predictive values of the test were 82.1% and 44.5%, respectively. A total of 76.4% infertile population was above this cutoff value compared to 46.7% of controls. Conclusions The luminol-based chemiluminescence assay can be used in routine diagnostic screening to test for male infertility diagnosis in a clinical setting. The current ROS cutoff value substantially distinguishes infertile from normal controls. Patients with elevated ROS must be evaluated for the underlying cause of ROS production.
Introduction
Free oxygen radicals such as superoxide anion (O 2− ), hydrogen peroxide (H 2 O 2 ), hypochlorite (OHCl), and hydroxyl radical (OH) are highly reactive oxygen species (ROS) [1, 2] . The production of these radicals occurs during normal metabolism of the cell. In semen, ROS are produced by spermatozoa and play a vital role in many physiologic processes of spermatozoa, such as acrosome reaction, capacitation, mitochondrial sheath stability, and fusion with oocyte [3] [4] [5] [6] . Seminal plasma contains several antioxidants and has a strong antioxidant capacity. For the continuity of normal physiological spermatozoa functions, a balance exists between seminal ROS and antioxidant capacity. An overproduction of ROS which exceeds the seminal plasma antioxidant capacity results in oxidative stress (OS), thereby inducing deleterious effects on spermatozoa function and, may consequently, lead to male infertility [5, [7] [8] [9] .
The harmful effects of higher levels of ROS have been documented on several sperm parameters including sperm concentration, motility, morphology, viability, and DNA fragmentation [1, 4, [10] [11] [12] [13] . Elevated ROS levels have also been reported in some clinical conditions (e.g., varicocele and reproductive tract infections) as well as in association with lifestyle choices (e.g., smoking) [14] [15] [16] [17] [18] . Similarly, low fertilization and pregnancy rates were achieved in couples in which the male partner had elevated seminal ROS levels [19, 20] .
Convincing evidence suggests that ROS levels have a positive impact on sperm function and male fertility if they are within the normal physiological range and effect negatively in uncontrolled production. Therefore, accurate measurement and defined cutoff values of ROS levels are important. The measurement of seminal ROS levels in infertile and fertile populations has been a challenge, requiring a method with high specificity and sensitivity. Previously, we published that elevated levels of ROS are directly related to male factor infertility [21] , and 91.9 RLU/s/10 6 sperm was considered a cutoff to distinguish between ROS negative and positive semen samples [22] . However, questions concerning the accuracy of this predictor of male factor fertility and cutoff values have yet to be fully answered.
The present study describes a detailed protocol for use in clinical laboratory for measurement of seminal ROS via luminol-based chemiluminescence assay. We also established ROS cutoff values in a large population of infertile patients and controls with or without proven fertility.
Material and methods

Selection of subjects
This study was approved by the Institutional Review Board of Cleveland Clinic. A total of 258 infertile men and 92 controls (with or without proven fertility) were enrolled in this study.
Inclusion criteria: All infertile men were attending the male infertility clinic for confirmed male factor infertility and evaluated by an infertility specialist. The female partner of these patients had gone through gynecological investigations and was declared normal.
Exclusion criteria Patients with cryptorchidism, azoospermia, retrograde ejaculate, partial ejaculate, or too low volume of ejaculate were excluded from the study. The controls comprised healthy male volunteers with normal semen analysis according to the WHO, 2010 guidelines [23] . Both men with proven and unproven fertility were included.
Semen collection and processing
Semen samples from patients and controls were collected by masturbation after 2-3 days of abstinence. After complete liquefaction for 20 min, basic semen analysis was performed according to WHO (5th Ed) guidelines [23] .
ROS levels were measured using luminol-based chemiluminescence assay. The principle and detailed protocol of the test is described below.
I. Principle
Luminol is extremely sensitive and reacts with a variety of ROS at neutral pH. It can measure both extracellular and intracellular ROS. The free radical combines with luminol to produce a light signal that is converted to an electrical signal (photon) by a luminometer. The number of free radicals produced is measured as relative light units/s/10 6 sperm. (PBS-1X; Catalog #9235, Irvine Scientific, Santa Ana, CA) III. Reagent preparation A. Luminol stock solution: 100 mM solution; 177.09 mg of luminol was weighed and added to 10 mL of DMSO solution in a polystyrene tube. The tube was covered with aluminum foil as luminol is light sensitive. This solution can be stored at room temperature until its expiration date. B. Working Luminol Solution: 5 mM solution; 20 μL of the luminol stock solution was mixed with 380 μL DMSO in a foil-covered polystyrene tube. It was prepared fresh prior to use. It can be stored at room temperature until needed and is stable for 24 h if not exposed to light. C. DMSO solution: It is provided ready to use and is stored in a dark container at room temperature until expiration date.
II. Equipment and materials
IV. Specimen preparation
A. The semen sample was allowed to undergo liquefaction in the 37°C incubator for 20 min. B. Patient's name, clinic number, period of sexual abstinence, date and time of specimen collection, and age of specimen when the semen analysis was performed was recorded. C. Initial physical characteristics such as volume, pH, color, etc. were also recorded. D. Five microliter of the well-mixed semen was loaded onto a counting chamber (MicroCell slide, Vitrolife Inc., San Diego, CA, USA). E. Semen analysis was performed using manual sperm count and motility. In addition, round cells were counted and the Endtz test was performed when the round cell concentration was greater than 1×10 6 / mL. V. ROS determination A. Luminometer was set up with a computer attached to it (Fig. 1a-c) .
B. 11 Falcon tubes (12×75 mm) were labeled in triplicate and the reagents were added as indicated in Table 1 ( Fig. 2) . Note: All readings were performed in the dark. C. It is important that the instrument settings are in place before adding reagents to the tube and loading samples. D. Reagents were added to the bottom of the tubes and not on the side. They were vortexed to ensure that the luminol was mixed with the rest of the reagent/ sample. E. The pipette tip was changed when adding reagent/ sample to each tube. F. Tubes were gently vortexed to mix the aliquots uniformly and to avoid bubbles. G. All the labeled tubes were placed in the luminometer in the following order: blank (tubes labeled 1-3), negative control (tubes labeled 4-6), test sample (tubes labeled 7-8), and positive control (tubes labeled 9-11) (Figs. 3 and 4) .
VI.
Analyzing the samples A. After the tubes were loaded, the "Start button was clicked. The luminometer will start scanning for tubes.
B. After scanning, the monitor will show how many tubes are detected by the instrument in each batch, press "Next." C. Select the "Assay Type." Click "Next" and then click 'Finish.' D. The "Excel spreadsheet" will open. E. Measurement of the tubes will start. F. Do not touch the computer during this time. G. Wait (3-5 min) to make sure everything is working fine. Fig. 3 Preparing the tubes for ROS measurement. A total of 11 tubes are labeled from S1-S11: Blank, negative control, test sample and positive control.
Luminol is added to all tubes except the blank. Hydrogen peroxide is added only to the positive control Fig. 2 Setup for reactive oxygen species testing; 3 blank controls, 3 negative controls, 2 patient sample tubes, and 3 positive controls H. After finishing the measurements, the computer will prompt to "Save" the Excel spreadsheet. Save it in "My Computer," in a folder under "Clinical ROS." I. Save Berthold measurement "Measurement Files" (*.txr) in the same directory as the Excel spreadsheet using the same name.
VII. Printing ROS results
A. Print spreadsheet as well as the "chart 1" and the Berthold sheet (Fig. 5) . B. Close the Excel spreadsheet.
C. Print the "Work Load" sheet (Fig. 6 ). Make sure all 3 sheets are printed before saving and closing the file.
VIII. Calculating results A. The "average RLU" for the negative control, samples and positive control was calculated. B. Sample ROS was calculated by subtracting the negative control average from its average. C. Sample ROS=average "RLU mean" for sample−average "RLU mean" for negative control. F. Repeated centrifugation can cause artificial increase in chemiluminescent signal because of the shearing forces generated by centrifugation. G. Use of media that contains serum albumin can generate spurious signals in the presence of human seminal plasma. H. Sensitivity of luminol to pH changes. I. Many compounds can artificially increase (e.g., cysteine or thiol-containing compounds) or decrease (e.g., ascorbate or uric acid) the chemiluminescent signal generated by spermatozoa. Hence, it is necessary to run sperm-free controls as an integral part of the chemiluminescent assay.
Statistical analysis
The Wilcoxon rank sum test was used for group comparison with respect to quantitative variables and chi square test with respect to categorical variables. The difference in the distribution of ROS levels between the two groups (control and patient) was assessed. A receiver operating characteristic (ROC) curve was used to assess the ability of ROS as a means of discriminating patients with controls. A cutoff value that Fig. 6 A typical graph showing the ROS levels in the 11 tubes (S1-S11). As seen here, only the positive controls have significantly higher levels of ROS. Those producing low levels (tubes S1-S8) of ROS are seen very close to the X-axis maximized the sum of estimated sensitivity and specificity was chosen. A p value of <0.05 was considered significant.
Results
ROC curve analysis
Test sensitivity, specificity, and positive and negative predictive values were calculated using ROC curve. Significantly, higher ROS levels were seen in infertile men compared to controls (p<0.001). The optimal cutoff value to distinguish between controls and infertile men was 102.2 RLU/s/10 6 sperm. At this cutoff value, the positive and negative predictive values of the test were 82.1% and 44.5%, respectively (Fig. 8) . The percentage of patients and controls above and below this cutoff value as well as sensitivity and specificity of the test are given in Table 2 .
ROS distribution by group
The distribution of the ROS levels in infertile patients and controls is given in Fig. 9 .
Discussion
In recent decades, male infertility has increased significantly due to a decline in semen quality and a concurrent increase in male reproductive pathologies. Linked to male infertility is OS, which has become a focus of interest and is implicated in its pathogenesis. A uniform consensus exists on the role of ROS in male fertility and infertility. Previous studies from our center have demonstrated that ROS is an independent factor of male factor infertility [4, 21] . We have reported different cutoff values for ROS in washed [2, 11, 24] and seminal ejaculates [4, 22] .
Before a test is recommended for clinical use, its reliability, repeatability, sensitivity, and accuracy must be validated. In this current study, we used liquefied or neat semen to measure ROS in infertile males and controls using the luminol-based chemiluminescence method.
Luminol-based chemiluminescence assay is a reliable technique for measuring seminal ROS [4] . Our goal was to establish a cutoff value of ROS and describe the methodology, which can serve as a guide for other laboratories. Our cutoff for ROS at which the test can effectively differentiate between infertile and control group was 102.2 RLU/s/10 6 sperm. At this value, the sensitivity and specificity of the test were 76.4 and 53.3%, respectively. Positive and negative predictive values (PPV and NPV) of the test were 82.1% and 44.5%, respectively. Overall, 68% of the population was above the cutoff value, while 31.4 % was below. When intra-group analysis was carried out, 76.4% of infertile population was above this cutoff compared to 46.7% of control. Only 23.6% of the infertile population was below this cutoff compared to 53.3% of control.
In our earlier study by Agarwal et al. [22] , the control group comprised only healthy men who had established a pregnancy (within 2 years or more than 2 years). The current study had a larger cohort that included both proven fertile and those who did not establish a pregnancy. This was a study limitation.
Therefore, sensitivity and specificity in this study are lower compared to our earlier study. The present cutoff of ROS suggests that any value above this threshold was still able to differentiate between subjects that were fertile from those who were not.
Physiological levels are necessary for the normal functions of sperm in capacitation, acrosome reaction, and zona binding. From our results, ROS levels below 102.2 RLU/s/10 6 sperm can be regarded as physiological levels, while those above this value should be considered pathological. Measurement of ROS levels can also serve a predictive tool in assisted reproduction [20, 25] . Deleterious effects of OS have been documented on fertilization rates in In vitro fertilization (IVF/ICSI) [19, 26] . In vitro addition of antioxidants into sperm preparation and oral intake of antioxidants have shown to increase the fertilization rates and pregnancy outcome [27] [28] [29] [30] . Furthermore, the negative impact of ROS on sperm DNA integrity has been shown in semen samples with high ROS levels. Agarwal et al. demonstrated that even in low levels of leukocytospermia, ROS levels are significantly increased compared to control that screened negative for leukocytes. [31] . This reveals the importance of ROS assessment in such patients, considering the fact that damaged sperm DNA has negative implications on fertilization rates and early embryo development.
Our goal was to provide a detailed protocol for the measurement of ROS using chemiluminescence assay to allow other diagnostic laboratories to establish this test in their labs and offer it to their patients. However, we recommend that controls of only proven fertility should be used so that the sensitivity and specificity can be further increased and the test employed as a screening/diagnostic test.
Taken together, we have demonstrated that the luminol-based chemiluminescence assay is sensitive and reliable in measuring ROS levels. The reproducibility of this test makes it a potential screening tool in male infertility investigations as well as a prognostic test for assisted reproduction outcomes. 
